Showing results (251-260 of 447) with videos related to

Sort By:
Pageof 45
Plos One|September 9, 2017
Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndromeXiangjun Chen, Øygunn Aass Utheim, Jiaxin Xiao, et al.
The Journal of Biological Chemistry|December 1, 2017
Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto- and heterologous virusesHua Wang, Xiangjun Chen, Dianhong Wang, et al.
Preventing Chronic Disease|July 3, 2020
Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney DiseaseLi Zheng, Xiangjun Chen, Ting Luo, et al.
Phenomics (Cham, Switzerland)|May 17, 2023
Presence of Rare Variants is Associated with Poorer Survival in Chinese Patients with Amyotrophic Lateral SclerosisSiqi Dong, Xianhong Yin, Kun Wang, et al.
International Journal of Biological Macromolecules|August 22, 2021
Pathogenic mechanism of congenital cataract caused by the CRYBA1/A3-G91del variant and related intervention strategiesJingjie Xu, Huaxia Wang, Chengpeng Wu, et al.
Frontiers in Oncology|July 3, 2025
Network pharmacology mechanisms and experimental verification of Hedyotis Diffusae Herba-Scutellariae Barbatae Herba drug pair extract in the treatment of nasopharyngeal carcinomaTiantian Li, Haijun Chen, Jing Zhang, et al.
Nanoscale|February 17, 2021
Amphiphilic Janus nanoparticles for imaging-guided synergistic chemo-photothermal hepatocellular carcinoma therapy in the second near-infrared windowXiangjun Chen, Xiuping Zhang, Lingyu Zhang, et al.
Journal of Neuroimmunology|April 17, 2025
Retinal layer thinning as a predictor of demyelinating diseases of the central nervous system: Insights from a decade-long cohort studyJiatong Li, Zexu Chen, Liu Yang, et al.
Muscle & Nerve|February 9, 2026
Lifestyle-Associated Metabolic Signature Predicts the Risk of Amyotrophic Lateral SclerosisJiatong Li, Dongqing Zhu, Wenbo Yang, et al.
Oncology Research|December 15, 2010
The insulin-like growth factor-1 receptor kinase inhibitor, NVP-ADW742, suppresses survival and resistance to chemotherapy in acute myeloid leukemia cellsYanli He, Jiahua Zhang, Jine Zheng, et al.
Pageof 45